The Oncology Pharmacist

To sign up for our newsletter or print publications, please enter your contact information below and click "Subscribe".

Already a subscriber? Enter your email address below and click "Find" to look up and manage your current contact details and subscription preferences.

Featured Articles

Centers for Disease Control and Prevention Guidelines on Opioid Use for Cancer Pain

Chase Doyle

Conference Correspondent, HOPA 2017 Highlights

The United States may be in the midst of an opioid epidemic, but the undertreatment of pain remains an issue for patients with cancer.

New Drug Therapies for Relapsed or Refractory Multiple Myeloma

Meg Barbor, MPH

Multiple Myeloma

Although the 5-year survival rate for multiple myeloma is less than 50%, this type of cancer has witnessed a resurgence of drug therapies.

The Evolving Role of Oncology Pharmacists

Interview

The Oncology Pharmacist (TOP) spoke with Steve Stricker, PharmD, MS, BCOP at the 2017 Hematology/Oncology Pharmacy Association (HOPA) Annual Conference about the importance of provider status, why clinical oncologists may be overlooked by their peers, and the most fulfilling part of his work.

Prescription Drug Use High Among Survivors of Childhood Cancers

Chase Doyle

Survivorship

Childhood cancer therapy can be a double-edged sword; it often leads to a cure, but long after treatment ends, some survivors have treatment-related side effects.